BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36508838)

  • 1. Aluminum induces neuroinflammation via P2X7 receptor activating NLRP3 inflammasome pathway.
    Zhu X; Hao W; Liu Z; Song Y; Hao C; Wu S; Lu X; Yang J; Jin C
    Ecotoxicol Environ Saf; 2023 Jan; 249():114373. PubMed ID: 36508838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminum exposure induces central nervous system impairment via activating NLRP3-medicated pyroptosis pathway.
    Hao W; Zhu X; Liu Z; Song Y; Wu S; Lu X; Yang J; Jin C
    Ecotoxicol Environ Saf; 2023 Oct; 264():115401. PubMed ID: 37634479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum impairs cognitive function by activating DDX3X-NLRP3-mediated pyroptosis signaling pathway.
    Hao W; Hao C; Wu C; Xu Y; Wu S; Lu X; Yang J; Jin C
    Food Chem Toxicol; 2021 Nov; 157():112591. PubMed ID: 34614429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2X7 Receptor-Induced Bone Cancer Pain by Regulating Microglial Activity via NLRP3/IL-1beta Signaling.
    Wu P; Wu X; Zhou G; Wang Y; Liu X; Lv R; Liu Y; Wen Q
    Pain Physician; 2022 Nov; 25(8):E1199-E1210. PubMed ID: 36375190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X
    Yin J; Wang Y; Hu H; Li X; Xue M; Cheng W; Wang Y; Li X; Yang N; Shi Y; Yan S
    J Cell Mol Med; 2017 Nov; 21(11):2695-2710. PubMed ID: 28470940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
    Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
    J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome.
    Wang W; Hu D; Feng Y; Wu C; Song Y; Liu W; Li A; Wang Y; Chen K; Tian M; Xiao F; Zhang Q; Chen W; Pan P; Wan P; Liu Y; Lan H; Wu K; Wu J
    BMC Biol; 2020 Nov; 18(1):182. PubMed ID: 33243234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.
    Zhao J; Wang H; Dai C; Wang H; Zhang H; Huang Y; Wang S; Gaskin F; Yang N; Fu SM
    Arthritis Rheum; 2013 Dec; 65(12):3176-85. PubMed ID: 24022661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.
    Yue N; Huang H; Zhu X; Han Q; Wang Y; Li B; Liu Q; Wu G; Zhang Y; Yu J
    J Neuroinflammation; 2017 May; 14(1):102. PubMed ID: 28486969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2X7 Receptor (P2X7R) of Microglia Mediates Neuroinflammation by Regulating (NOD)-Like Receptor Protein 3 (NLRP3) Inflammasome-Dependent Inflammation After Spinal Cord Injury.
    Fan X; Ma W; Zhang Y; Zhang L
    Med Sci Monit; 2020 Sep; 26():e925491. PubMed ID: 32952148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripartite-motif protein 21 knockdown extenuates LPS-triggered neurotoxicity by inhibiting microglial M1 polarization via suppressing NF-κB-mediated NLRP3 inflammasome activation.
    Xiao T; Wan J; Qu H; Li Y
    Arch Biochem Biophys; 2021 Jul; 706():108918. PubMed ID: 33992596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.
    Thawkar BS; Kaur G
    J Neuroimmunol; 2019 Jan; 326():62-74. PubMed ID: 30502599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes.
    Gustin A; Kirchmeyer M; Koncina E; Felten P; Losciuto S; Heurtaux T; Tardivel A; Heuschling P; Dostert C
    PLoS One; 2015; 10(6):e0130624. PubMed ID: 26091541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome.
    Hou XX; Dong HR; Sun LJ; Yang M; Cheng H; Chen YP
    Chin Med J (Engl); 2018 Nov; 131(22):2713-2725. PubMed ID: 30425198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer.
    Bae JY; Lee SW; Shin YH; Lee JH; Jahng JW; Park K
    Oncotarget; 2017 Jul; 8(30):48972-48982. PubMed ID: 28430665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of P2X7 attenuates acute lung injury in mice by inhibiting NLRP3 inflammasome.
    Wang S; Zhao J; Wang H; Liang Y; Yang N; Huang Y
    Int Immunopharmacol; 2015 Jul; 27(1):38-45. PubMed ID: 25937482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of P2X7 Purinergic Receptor Ameliorates Fibromyalgia Syndrome by Suppressing NLRP3 Pathway.
    D'Amico R; Fusco R; Siracusa R; Impellizzeri D; Peritore AF; Gugliandolo E; Interdonato L; Sforza AM; Crupi R; Cuzzocrea S; Genovese T; Cordaro M; Di Paola R
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo.
    He Y; Franchi L; Núñez G
    J Immunol; 2013 Jan; 190(1):334-9. PubMed ID: 23225887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-canonical NLRP3 inflammasome activation and IL-1β signaling are necessary to L. amazonensis control mediated by P2X7 receptor and leukotriene B4.
    Chaves MM; Sinflorio DA; Thorstenberg ML; Martins MDA; Moreira-Souza ACA; Rangel TP; Silva CLM; Bellio M; Canetti C; Coutinho-Silva R
    PLoS Pathog; 2019 Jun; 15(6):e1007887. PubMed ID: 31233552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanol upregulates the P2X7 purinergic receptor in human macrophages.
    Le Daré B; Victoni T; Bodin A; Vlach M; Vene E; Loyer P; Lagente V; Gicquel T
    Fundam Clin Pharmacol; 2019 Feb; 33(1):63-74. PubMed ID: 30447168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.